Ahmedabad Covid-19 samples detected with Delta, Kappa variants

Ahmedabad district has, so far, reported 2,38,410 Covid-19 cases, of which 63 are active

Topics
Coronavirus Vaccine | Coronavirus Tests | Ahmedabad

Press Trust of India  |  Ahmedabad 

A health worker takes swab sample of a passenger to test for Covid-19 test at the Dadar railway station in Mumbai, Thursday, Aug. 5, 2021. (PTI Photo/Shashank Parade)
A health worker takes swab sample of a passenger to test for Covid-19 (File Photo: PTI)

Samples of COVID-19 patients from in Gujarat sent for genome sequencing to a laboratory in Pune in Maharashtra in August and September were found to be infected with both 'Delta' and 'Kappa' variants, an official said here on Sunday.

Out of two samples sent to the Pune laboratory in August, one each was detected with Delta and Kappa variants of coronavirus, while one sample sent in September had the Delta variant, said Dr Kanu Patel of the microbiology department of the government-run BJ Medical College here.

"Results are awaited for samples of COVID-19 patients sent for genome sequencing in October to the Institute of Virology in Pune. No sample has been sent in November so far," he added.

The Delta variant was first detected in India in October last year, and continues to be the main variant of concern, which had also played a major role in the second wave of the pandemic that peaked in April-May this year, while Kappa is a variant of interest and comparatively moderate.

district has, so far, reported 2,38,410 COVID-19 cases, of which 63 are active, while Gujarat's caseload stands at 8,26,950, with 230 being active ones.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Sun, November 14 2021. 21:34 IST
RECOMMENDED FOR YOU